Sartorius Stedim Biotech Stock Market Value
| SDMHF Stock | USD 176.10 1.90 1.07% |
| Symbol | Sartorius |
Sartorius Stedim 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Sartorius Stedim's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Sartorius Stedim.
| 10/28/2024 |
| 11/27/2024 |
If you would invest 0.00 in Sartorius Stedim on October 28, 2024 and sell it all today you would earn a total of 0.00 from holding Sartorius Stedim Biotech or generate 0.0% return on investment in Sartorius Stedim over 30 days. Sartorius Stedim is related to or competes with GlucoTrack, Sharps Technology, Utah Medical, Innovative Eyewear, and Microbot Medical. Sartorius Stedim Biotech S.A. produces and sells instruments and consumables for the biopharmaceutical industry worldwid... More
Sartorius Stedim Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Sartorius Stedim's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Sartorius Stedim Biotech upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.06) | |||
| Maximum Drawdown | 21.13 | |||
| Value At Risk | (8.06) | |||
| Potential Upside | 6.04 |
Sartorius Stedim Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Sartorius Stedim's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Sartorius Stedim's standard deviation. In reality, there are many statistical measures that can use Sartorius Stedim historical prices to predict the future Sartorius Stedim's volatility.| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | (0.15) | |||
| Total Risk Alpha | (0.63) | |||
| Treynor Ratio | (0.13) |
Sartorius Stedim Biotech Backtested Returns
Sartorius Stedim Biotech owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0281, which indicates the firm had a -0.0281% return per unit of risk over the last 3 months. Sartorius Stedim Biotech exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Sartorius Stedim's Coefficient Of Variation of (5,068), risk adjusted performance of (0.01), and Variance of 12.49 to confirm the risk estimate we provide. The entity has a beta of 0.6, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Sartorius Stedim's returns are expected to increase less than the market. However, during the bear market, the loss of holding Sartorius Stedim is expected to be smaller as well. At this point, Sartorius Stedim Biotech has a negative expected return of -0.1%. Please make sure to validate Sartorius Stedim's total risk alpha, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if Sartorius Stedim Biotech performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.50 |
Modest predictability
Sartorius Stedim Biotech has modest predictability. Overlapping area represents the amount of predictability between Sartorius Stedim time series from 28th of October 2024 to 12th of November 2024 and 12th of November 2024 to 27th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Sartorius Stedim Biotech price movement. The serial correlation of 0.5 indicates that about 50.0% of current Sartorius Stedim price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.5 | |
| Spearman Rank Test | -0.54 | |
| Residual Average | 0.0 | |
| Price Variance | 110.33 |
Sartorius Stedim Biotech lagged returns against current returns
Autocorrelation, which is Sartorius Stedim pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Sartorius Stedim's pink sheet expected returns. We can calculate the autocorrelation of Sartorius Stedim returns to help us make a trade decision. For example, suppose you find that Sartorius Stedim has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Sartorius Stedim regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Sartorius Stedim pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Sartorius Stedim pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Sartorius Stedim pink sheet over time.
Current vs Lagged Prices |
| Timeline |
Sartorius Stedim Lagged Returns
When evaluating Sartorius Stedim's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Sartorius Stedim pink sheet have on its future price. Sartorius Stedim autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Sartorius Stedim autocorrelation shows the relationship between Sartorius Stedim pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Sartorius Stedim Biotech.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in Sartorius Pink Sheet
Sartorius Stedim financial ratios help investors to determine whether Sartorius Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sartorius with respect to the benefits of owning Sartorius Stedim security.